Catalyst Wire Dossier Catalyst Wire Dossier

Babaodan

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Babaodan, covering 2018-05-03 to 2018-05-03. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma [Phase 4]

See pricing